Managed care plan biomarker testing.

(1) A managed care plan must provide coverage for biomarker testing for recipients, as authorized under s. 409.906, at the same scope, duration, and frequency as the Medicaid program provides for other medically necessary treatments.

(a) A recipient and health care provider shall have access to a clear and convenient process to request authorization for biomarker testing as provided under this section. Such process shall be made readily accessible on the website of the managed care plan.

(b) This section does not require coverage of biomarker testing for screening purposes.

(c) The agency shall include the rate impact of this section in the applicable Medicaid managed medical assistance program and long-term care managed care program rates.

(2) A managed care plan must provide coverage for blood-based biomarker tests for colorectal cancer screening covered under a National Coverage Determination from the Centers for Medicare and Medicaid Services at the same scope and frequency as described in the National Coverage Determination.